Table 32.
Combined resistance to fluoroquinolones and third‐generation cephalosporins in indicator Escherichia coli from fattening pigs, 11 EU MSs, 2017
| Country | N | MDR patterns of isolates exhibiting combined resistance to CIP and CTX (number of isolates) | Microbiological Combined Resistance to CIP and CTXa | Clinical Combined Resistance to CIP and CTXb | ||
|---|---|---|---|---|---|---|
| n | %r | n | %r | |||
| Belgium | 176 | AMP‐CTX‐CAZ‐CHL‐CIP‐SMX‐TMP (1) | 5 | 2.8 | 1 | 0.6 |
| AMP‐CTX‐CAZ‐CIP‐NAL‐SMX‐TET‐TMP (2) | ||||||
| AMP‐CTX‐CAZ‐CIP‐NAL‐SMX‐TMP (1) | ||||||
| AMP‐CTX‐CAZ‐CIP‐TET (1) | ||||||
| Czech Republic | 180 | AMP‐CTX‐CAZ‐CIP‐NAL‐TMP (1) | 1 | 0.6 | 1 | 0.6 |
| Germany | 227 | AMP‐CTX‐CAZ‐CIP‐NAL‐SMX‐TMP (2) | 3 | 1.3 | 2 | 0.9 |
| AMP‐CTX‐CAZ‐CIP‐TET (1) | ||||||
| Ireland | 203 | AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET (1) | 2 | 1 | ||
| AMP‐CTX‐CAZ‐CIP‐GEN‐NAL‐TMP (1) | ||||||
| Italy | 170 | AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET (1) | 1 | 0.6 | ||
| Latvia | 149 | AMP‐CTX‐CAZ‐CIP‐GEN‐SMX‐TET‐TMP (1) | 1 | 0.7 | ||
| Poland | 213 | AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET‐TMP (1) | 2 | 0.9 | ||
| AMP‐CTX‐CAZ‐CIP‐SMX‐TMP (1) | ||||||
| Portugal | 142 | AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET‐TMP (1) | 3 | 2.1 | 1 | 0.7 |
| AMP‐CTX‐CAZ‐CIP‐NAL‐SMX‐TET‐TMP (1) | ||||||
| AMP‐CTX‐CAZ‐CIP‐TET (1) | ||||||
| Romania | 170 | AMP‐CTX‐CAZ‐CHL‐CIP‐GEN‐NAL‐SMX‐TET‐TMP (1) | 3 | 1.8 | 1 | 0.6 |
| AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET‐TMP (1) | ||||||
| AMP‐CTX‐CAZ‐CHL‐CIP‐SMX‐TET (1) | ||||||
| Slovenia | 85 | AMP‐CTX‐CAZ‐CIP‐NAL (1) | 1 | 1.2 | 1 | 1.2 |
| Spain | 170 | AMP‐CTX‐CAZ‐CHL‐CIP‐NAL‐SMX‐TET‐TMP (1) | 2 | 1.2 | ||
| AMP‐CTX‐CAZ‐CIP‐NAL‐TET‐TMP (1) | ||||||
| Total (11 MSs) | 1,885 | – | 24 | 1.3 | 7 | 0.4 |
ECOFFs: epidemiological cut‐off values; MSs: Member States; N: number of isolates tested; GEN: gentamicin; CHL: chloramphenicol; AMP: ampicillin; CTX: cefotaxime; CAZ: Ceftazidime; TGC: tigecycline; NAL: nalidixic acid; CIP: ciprofloxacin; COL: colistin; SMX: sulfamethoxazole; TMP: trimethoprim; TET: tetracycline.
a
applying ECOFFs.
b
applying CBPs.